Published in Autoimmunity on January 01, 1995
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology (2005) 3.18
Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest (2002) 2.56
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest (2002) 1.98
Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol (2003) 1.81
Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis. J Clin Invest (2000) 1.60
Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci U S A (2002) 1.55
Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med (2007) 1.44
Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther (2006) 1.32
Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest (2004) 1.28
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells. Mol Ther Nucleic Acids (2012) 1.24
A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis. J Exp Med (2007) 1.22
Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology (2006) 1.21
Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J Immunol (2014) 1.19
Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J (2008) 1.19
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol (2010) 1.16
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis. Arthritis Res Ther (2010) 1.14
The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol (2005) 1.13
Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res Ther (2004) 1.11
Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J Immunol (2008) 1.01
Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice. Immunology (2000) 0.97
Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis. Arthritis Res Ther (2008) 0.96
Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther (2005) 0.96
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. J Clin Invest (2014) 0.95
Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis. Arthritis Res Ther (2012) 0.92
G-protein signaling modulator-3, a gene linked to autoimmune diseases, regulates monocyte function and its deficiency protects from inflammatory arthritis. Mol Immunol (2012) 0.91
Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis. Autoimmune Dis (2015) 0.89
Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis (2005) 0.88
Oncostatin M in the anti-inflammatory response. Ann Rheum Dis (2001) 0.86
Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody. Ann Rheum Dis (1999) 0.85
Kruppel-like factor 5 causes cartilage degradation through transactivation of matrix metalloproteinase 9. J Biol Chem (2008) 0.85
Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease. Arthritis Res Ther (2008) 0.83
Administration of anti-type II collagen antibody sustains footpad swelling of mice caused by a delayed-type hypersensitivity reaction and induces severe arthritis. Clin Exp Immunol (2007) 0.83
Blocking platelet/endothelial cell adhesion molecule 1 (PECAM) inhibits disease progression and prevents joint erosion in established collagen antibody-induced arthritis. Exp Mol Pathol (2009) 0.82
The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice. Br J Pharmacol (2000) 0.81
Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro. Arthritis Res Ther (2005) 0.80
Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1. Inflammation (2009) 0.79
Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNFα in rheumatoid arthritis. J Transl Med (2014) 0.78
Immunity to type IX collagen in rodents: a study of type IX collagen for autoimmune and arthritogenic activities. Clin Exp Immunol (1998) 0.77
Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity. J Inflamm (Lond) (2011) 0.76
Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxins: results of an open-labelled pilot study. Nutr J (2011) 0.76
No mixing of granulocytes and other lymphocytes in the inflamed joints of parabiosis mice with collagen-induced arthritis: possible in situ generation. Immunology (2005) 0.75
A noncontact footpad thickness assay to evaluate rheumatoid disease. Rheumatol Int (2009) 0.75
Rheumatoid arthritis following ciguatera poisoning: A case report. J Rural Med (2017) 0.75
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem (1985) 3.15
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A (1998) 3.04
Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A (1978) 3.00
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64
Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest (1976) 2.60
U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts. Nucleic Acids Res (1991) 2.49
Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol (1999) 2.24
Collagen-induced arthritis, an animal model of autoimmunity. Life Sci (1997) 2.20
Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules. J Immunol (1984) 2.18
Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence. J Infect Dis (1990) 2.17
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infect Immun (1994) 2.15
FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol (1994) 2.01
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. J Exp Med (1983) 1.96
Localization of protective epitopes within the pilin subunit of the Vibrio cholerae toxin-coregulated pilus. Infect Immun (1991) 1.90
Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen. Histochem Cell Biol (1995) 1.88
Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol (1995) 1.82
Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J Exp Med (1983) 1.82
Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum (1981) 1.79
Adherence of Streptococcus sanguis to conformationally specific determinants in fibronectin. Infect Immun (1988) 1.77
Freeze-fracture studies of the developing cell surface. II. Particle-free membrane blisters on glutaraldehyde-fixed corneal fibroblasts are artefacts. J Cell Biol (1978) 1.76
Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J Biol Chem (1997) 1.72
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun (1985) 1.71
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest (1977) 1.68
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol (1995) 1.67
HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med (1996) 1.66
Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes. Mol Microbiol (1999) 1.61
A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet (1996) 1.60
Binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun (1986) 1.58
Linker insertion analysis of the FimH adhesin of type 1 fimbriae in an Escherichia coli fimH-null background. FEMS Microbiol Lett (1996) 1.54
Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J Immunol (1986) 1.54
Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med (1982) 1.53
Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem (1980) 1.50
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Identification of specific sites in the TNF-alpha molecule promoting insulin resistance in H-411E cells. J Lab Clin Med (1997) 1.49
Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43
The remineralizing effect of an essential oil fluoride mouthrinse in an intraoral caries test. J Am Dent Assoc (2004) 1.42
Processing of TCP pilin by TcpJ typifies a common step intrinsic to a newly recognized pathway of extracellular protein secretion by gram-negative bacteria. Genes Dev (1991) 1.40
New protective antigen of group A streptococci. J Clin Invest (1999) 1.39
Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med (1989) 1.39
Fragmentation of Escherichia coli type 1 fimbriae exposes cryptic D-mannose-binding sites. J Bacteriol (1991) 1.38
Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem (2000) 1.38
Leucine periodicity of U2 small nuclear ribonucleoprotein particle (snRNP) A' protein is implicated in snRNP assembly via protein-protein interactions. Mol Cell Biol (1991) 1.37
Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2. Proc Natl Acad Sci U S A (1985) 1.36
Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect Immun (1992) 1.31
Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest (1985) 1.30
Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis. Infect Immun (1994) 1.28
Isolation, characterization and immunolocalization of a 53-kDal dentin sialoprotein (DSP). Matrix (1992) 1.27
Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a. Infect Immun (1993) 1.25
Genetic control of collagen-induced arthritis in rats: the immune response to type II collagen among susceptible and resistant strains and evidence for multiple gene control. J Immunol (1984) 1.24
Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides. Virus Res (1986) 1.24
Transcriptional regulation of type I collagen genes in cultured fibroblasts by a factor isolated from thioacetamide-induced fibrotic rat liver. J Biol Chem (1984) 1.23
Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem. J Exp Med (1987) 1.23
Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol (1992) 1.22
Growth and acid tolerance of human dental plaque bacteria. Arch Oral Biol (1984) 1.22
Alterations in collagen production in mixed mononuclear leukocyte-fibroblast cultures. J Exp Med (1983) 1.22
Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages. Biochem Biophys Res Commun (1980) 1.21
Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum (1993) 1.21
Peptide-specific antibodies identify the alpha 2 chain as the proteoglycan subunit of type IX collagen. J Biol Chem (1986) 1.20
Lipoteichoic acid and M protein: dual adhesins of group A streptococci. Microb Pathog (1992) 1.20
Isolation and characterization of a 60-kilodalton salivary glycoprotein with agglutinating activity against strains of Streptococcus mutans. Infect Immun (1986) 1.19
Binding of fibronectin to human buccal epithelial cells inhibits the binding of type 1 fimbriated Escherichia coli. Infect Immun (1985) 1.17
Covalent structure of collagen: amino acid sequence of alpha 1(III)-CB9 from type III collagen of human liver. Biochemistry (1981) 1.17
T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J Immunol (1993) 1.16
Aggregation of group A streptococci by human saliva and effect of saliva on streptococcal adherence to host cells. Infect Immun (1991) 1.16
Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases. J Immunol (1998) 1.15
Freeze-fracture studies of the developing cell surface. I. The plasmalemma of the corneal fibroblast. J Cell Biol (1977) 1.14
Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein. J Immunol (1987) 1.13
Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med (1988) 1.12
Induction of arthritis in DA rats by incomplete Freund's adjuvant. J Rheumatol (1993) 1.12
Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12
cDNA cloning and expression of platelet p24/CD9. Evidence for a new family of multiple membrane-spanning proteins. J Biol Chem (1991) 1.11
Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages. Coll Relat Res (1984) 1.11
Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171. J Clin Invest (1989) 1.11
Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. Am J Physiol (1992) 1.10
Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem (1986) 1.10
An epitope proximal to the carboxyl terminus of the alpha-subunit is located near the lobe tips of the phosphorylase kinase hexadecamer. J Mol Biol (1994) 1.09
A 28-kilodalton fibronectin-binding protein of group A streptococci. Curr Microbiol (1992) 1.08
Chronic arthropathy associated with rubella vaccination. Arthritis Rheum (1977) 1.07
Binding of chemotactic collagen-derived peptides to fibroblasts. The relationship to fibroblast chemotaxis. J Clin Invest (1978) 1.07
Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol (1980) 1.07
The isolation of two types of collagen from embryonic bovine epiphyseal cartilage. Calcif Tissue Res (1974) 1.05
Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol (1995) 1.05
Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol (1983) 1.04
Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol (1996) 1.04